Indication
Abuse
6 clinical trials
22 products
1 drug
Clinical trial
A Double-Blind, Randomized, Crossover Study to Assess the Abuse Potential of Intranasal Cebranopadol Compared to Oxycodone and Placebo in Healthy, Nondependent Recreational Opioid UsersStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Product
CebranopadolProduct
Treatment AProduct
Treatment BProduct
Treatment CProduct
QualificationClinical trial
Analgesic and Subjective Effects of Terpenes Administered Alone and in Combination With THCStatus: Recruiting, Estimated PCD: 2024-10-15
Product
Low THCProduct
High THCProduct
MyrceneProduct
High MyrceneProduct
Beta-CaryophylleneProduct
High Beta-CaryophylleneProduct
PlaceboClinical trial
Sex-dependent Effects of Cannabis: Assessing Analgesic, Abuse-related and Pharmacokinetic Differences Between Men and WomenStatus: Recruiting, Estimated PCD: 2025-06-30
Product
Active CannabisProduct
Placebo CannabisClinical trial
Effects of Cannabis on Prescription Drug Abuse Liability and AnalgesiaStatus: Completed, Estimated PCD: 2022-12-06
Product
OxycodoneProduct
CannabisDrug
VarlilumabClinical trial
Analgesic and Appetite-stimulating Effects of Cannabigerol Administered Alone and in Combination With Delta-9-tetrahydrocannabinolStatus: Recruiting, Estimated PCD: 2024-12-22
Product
Low CBGProduct
High CBGProduct
THCClinical trial
Sex- and AGE-dependent Effects of Smoked and Oral Delta-9-THCStatus: Not yet recruiting, Estimated PCD: 2027-08-01
Product
DronabinolProduct
Smoked PlaceboProduct
Oral Placebo